https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf
Wells Fargo Upgrades Eli Lilly to Overweight, Raises Price Target to $375
Wells Fargo analyst Mohit Bansal upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and raises the price target from $360 to $375.